MeSH term
Frequency | Condition_Probility | Aged | 8 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Female | 24 | 0.0 |
Humans | 89 | 0.0 |
Animals | 62 | 0.0 |
Antibody Specificity | 5 | 0.0 |
Disaccharides/*immunology | 8 | 44.0 |
Graft Rejection/immunology | 3 | 4.0 |
Hybridomas/immunology | 3 | 2.0 |
Mice | 21 | 0.0 |
Swine | 24 | 1.0 |
Transplantation, Heterologous | 3 | 0.0 |
Animals, Genetically Modified | 2 | 0.0 |
Papio | 10 | 6.0 |
Research Support, Non-U.S. Gov't | 53 | 0.0 |
Time Factors | 6 | 0.0 |
Transplantation, Heterologous/*immunology | 3 | 5.0 |
Adult | 16 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Male | 23 | 0.0 |
Middle Aged | 10 | 0.0 |
Prognosis | 3 | 0.0 |
Child | 4 | 0.0 |
Radioligand Assay | 2 | 0.0 |
Receptors, Galanin | 5 | 16.0 |
Survival Rate | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Galanin/*metabolism | 4 | 57.0 |
Ligands | 2 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Molecular Sequence Data | 22 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Epitopes/genetics | 2 | 2.0 |
Galactosyltransferases/*biosynthesis/genetics | 2 | 100.0 |
Fluorescent Antibody Technique | 4 | 0.0 |
3T3 Cells/metabolism | 2 | 7.0 |
Adenoviruses, Human/*genetics | 3 | 1.0 |
Cell Line | 7 | 0.0 |
Disaccharides/*biosynthesis | 3 | 100.0 |
Embryo | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Kidney/*cytology | 2 | 20.0 |
Transfection | 4 | 0.0 |
Gene Expression | 3 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Antigens, Heterophile/*immunology | 4 | 33.0 |
Galactosyltransferases/*deficiency/genetics | 2 | 100.0 |
Disaccharides/*metabolism | 2 | 33.0 |
Galactosyltransferases/*genetics | 4 | 40.0 |
Binding Sites | 4 | 0.0 |
Fungal Proteins/genetics/*metabolism | 2 | 3.0 |
Gene Expression Regulation, Fungal | 2 | 2.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Asialoglycoproteins/*metabolism | 2 | 40.0 |
Heterozygote | 2 | 0.0 |
Infant, Newborn | 3 | 0.0 |
*Mass Screening | 2 | 3.0 |
Acute Disease | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Epitopes/immunology | 3 | 0.0 |
Rats | 7 | 0.0 |
Transplantation, Heterologous/*immunology/pathology | 3 | 50.0 |
Binding Sites, Antibody | 2 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
Immunity, Natural | 2 | 0.0 |
Immunoglobulin M/metabolism | 2 | 2.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Cytotoxicity, Immunologic | 2 | 0.0 |
Enzyme Stability | 2 | 1.0 |
Kinetics | 7 | 0.0 |
Lectins | 3 | 3.0 |
Plant Lectins | 2 | 4.0 |
Adolescent | 4 | 0.0 |
Area Under Curve | 2 | 0.0 |
Antibodies, Monoclonal/*chemistry | 2 | 5.0 |
Binding, Competitive | 4 | 0.0 |
Models, Molecular | 3 | 0.0 |
Galactose/*immunology | 2 | 40.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Base Sequence | 5 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Disaccharides/immunology | 4 | 44.0 |
Glycosylation | 3 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Antibodies/*immunology | 2 | 1.0 |
Epitopes | 4 | 0.0 |
Immunization | 2 | 0.0 |
*Kidney Transplantation | 2 | 0.0 |
*Transplantation, Heterologous | 5 | 7.0 |
Flow Cytometry | 3 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
Breast Neoplasms/immunology | 2 | 5.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Comparative Study | 11 | 0.0 |
Species Specificity | 4 | 0.0 |
Antibodies, Heterophile/*immunology | 3 | 37.0 |
Graft Rejection/*prevention & control | 2 | 4.0 |
Cell Survival | 2 | 0.0 |
Complement 3/metabolism | 2 | 0.0 |
Carbohydrate Conformation | 8 | 6.0 |
Carbohydrate Sequence | 15 | 4.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Corticotropin/*blood | 2 | 3.0 |
Galanin/*blood | 4 | 44.0 |
Norepinephrine/*blood | 2 | 3.0 |
Reference Values | 2 | 0.0 |
Complement Hemolytic Activity Assay | 2 | 4.0 |
Kidney/immunology | 3 | 7.0 |
Oligosaccharides/*immunology | 2 | 22.0 |
Structure-Activity Relationship | 2 | 0.0 |
Disaccharides/*immunology/*metabolism | 2 | 100.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Substrate Specificity | 3 | 0.0 |
*Lewis Blood-Group System | 2 | 25.0 |
Epinephrine/blood | 2 | 1.0 |
Galanin | 6 | 15.0 |
Heart Rate/drug effects | 2 | 0.0 |
Peptides/administration & dosage/*pharmacology | 2 | 22.0 |
Epitopes/*immunology | 3 | 1.0 |
Graft Survival | 2 | 0.0 |
Infusions, Intravenous | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Polysaccharides/*biosynthesis | 2 | 22.0 |
Chromatography, Gel | 2 | 0.0 |
Magnetic Resonance Spectroscopy/methods | 2 | 4.0 |
English Abstract | 3 | 0.0 |
*Glycoproteins | 2 | 0.0 |
Rats, Inbred Strains | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
